全球萤光导引手术系统市场规模、份额、趋势和成长分析报告（2026-2034）

预计萤光导引手术系统市场将从 2025 年的 1.5234 亿美元成长到 2034 年的 5.1978 亿美元，2026 年至 2034 年的复合年增长率为 14.61%。

受外科技术进步和精准手术需求不断增长的推动，全球萤光引导手术系统市场持续成长。萤光导引手术利用专用影像系统和萤光染料，在手术过程中清楚显示组织、肿瘤和血管。这项技术使外科医生能够更好地了解关键结构，并进行更精准的手术。

癌症手术和复杂医疗程序数量的不断增加是市场成长的主要驱动力。外科医师越来越多地采用萤光成像技术来提高肿瘤检测的准确性，并降低误切除正常组织的风险。影像系统、相机和萤光染料的进步正在提高这些手术工具的准确性和有效性。

随着医院持续投资于先进的外科技术，市场预计将会扩大。医学影像和萤光标记研究的进步将进一步提高手术的精确度。随着微创手术的日益普及，萤光导引手术系统将在现代手术室中发挥越来越重要的作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球萤光导引手术系统市场：依类型划分

• 市场分析、洞察与预测
• 间谍系统
• 光动力眼（PDE）系统
• VS3铱星系统
• 其他类型

第五章：全球萤光导引手术系统市场：依手术类型划分

• 市场分析、洞察与预测
• 开放性手术
• 腹腔镜手术/内视镜手术

第六章：全球萤光导引手术系统市场：依应用领域划分

• 市场分析、洞察与预测
• 癌症手术
• 心血管外科
• 其他用途

第七章 全球萤光导引手术系统市场：依最终用途划分

• 市场分析、洞察与预测
• 医院和诊所
• 门诊手术中心
• 肿瘤中心
• 其他最终用户

第八章：全球萤光导引手术系统市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • B. Braun
  • Carl Zeiss
  • Danaher Corporation
  • Getinge
  • Hamamatsu Photonics
  • Intuitive Surgical
  • KARL STORZ
  • Medtronic
  • Olympus Corporation
  • OnLume
  • Shimadzu Corporation
  • Stryker Corporation
  • Samvardhana Motherson International
  • Sumitomo Mitsui Financial Group

The Fluorescence Guided Surgery Systems Market size is expected to reach USD 519.78 Million in 2034 from USD 152.34 Million (2025) growing at a CAGR of 14.61% during 2026-2034.

The global fluorescence guided surgery systems market is growing as surgical technologies advance and demand for precision-based procedures increases. Fluorescence guided surgery uses special imaging systems and fluorescent dyes to highlight tissues, tumors, or blood vessels during surgical procedures. This technology allows surgeons to visualize critical structures more clearly and perform more accurate operations.

The rising number of cancer surgeries and complex medical procedures is a major factor driving market growth. Surgeons are increasingly adopting fluorescence imaging technologies to improve tumor detection and reduce the risk of removing healthy tissues. Advances in imaging systems, cameras, and fluorescent agents are enhancing the accuracy and effectiveness of these surgical tools.

In the future, the market is expected to expand as hospitals continue investing in advanced surgical technologies. Ongoing research in medical imaging and fluorescent biomarkers will further improve surgical precision. As minimally invasive procedures become more common, fluorescence guided surgery systems will play an increasingly important role in modern operating rooms.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• SPY System
• Photo Dynamic Eye (PDE) System
• VS3 Iridium System
• Other Types

By Surgery

• Open Surgery
• Laparoscopic/Endoscopic Surgery

By Application

• Cancer Surgeries
• Cardiovascular Surgeries
• Other Applications

By End Use

• Hospitals And Clinics
• Ambulatory Surgery Centers
• Oncology Centers
• Other End Users

COMPANIES PROFILED

• B Braun, Carl Zeiss, Danaher Corporation, Getinge, Hamamatsu Photonics, Intuitive Surgical, KARL STORZ, Medtronic, Olympus Corporation, OnLume, Shimadzu Corporation, Stryker Corporation, Samvardhana Motherson International, Sumitomo Mitsui Financial Group
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEMS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. SPY System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Photo Dynamic Eye (PDE) System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. VS3 Iridium System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEMS MARKET: BY SURGERY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Surgery
• 5.2. Open Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Laparoscopic/Endoscopic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEMS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cancer Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiovascular Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEMS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Oncology Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEMS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Surgery
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Surgery
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Surgery
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Surgery
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Surgery
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEMS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 B. Braun
  • 10.2.2 Carl Zeiss
  • 10.2.3 Danaher Corporation
  • 10.2.4 Getinge
  • 10.2.5 Hamamatsu Photonics
  • 10.2.6 Intuitive Surgical
  • 10.2.7 KARL STORZ
  • 10.2.8 Medtronic
  • 10.2.9 Olympus Corporation
  • 10.2.10 OnLume
  • 10.2.11 Shimadzu Corporation
  • 10.2.12 Stryker Corporation
  • 10.2.13 Samvardhana Motherson International
  • 10.2.14 Sumitomo Mitsui Financial Group